| 1 |
Targeted Therapies in Trial for Non-Resectable Gallbladder Cancer |
|
|
| Ali A. Nasrallah,Hussein H. Khachfe,Hamza A. Salhab,Mohamad Y. Fares,Jawad Fares |
|
| Journal of Gastrointestinal Cancer. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection |
|
|
| Qingguo Li,Weixing Dai,Yaqi Li,Ye Xu,Xinxiang Li,Sanjun Cai |
|
| Scientific Reports. 2017; 7: 46345 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Molecular profiles in foregut oncology |
|
|
| Prashant Sukharamwala,Daniel Hennessey,Thomas Wood,Shelly Singh,Carrie Ryan,Alexander Rosemurgy |
|
| Cancer Genetics. 2016; 209(12): 537 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Predictors of incidental gallbladder cancer in elderly patients |
|
|
| Ji-Qiao Zhu,Dong-Dong Han,Xian-Liang Li,Jian-Tao Kou,Hua Fan,Qiang He |
|
| Hepatobiliary & Pancreatic Diseases International. 2015; 14(1): 96 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Gallbladder Cancer in the 21st Century |
|
|
| Rani Kanthan,Jenna-Lynn Senger,Shahid Ahmed,Selliah Chandra Kanthan |
|
| Journal of Oncology. 2015; 2015: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Upregulated plasma and urinary levels of nucleosides as biological markers in the diagnosis of primary gallbladder cancer |
|
|
| Xingyuan Jiao,Yuxuan Mo,Ying Wu,Jinyun He,Peng Zhang,Ronglin Hu,Canqiao Luo,Jun Du,Jian Fu,Jinsen Shi,Liansuo Zhou,Dongming Li |
|
| Journal of Separation Science. 2014; : n/a |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Gallbladder cancers |
|
|
| Andrea Cariati,Elisa Piromalli,Francesco Cetta |
|
| European Journal of Gastroenterology & Hepatology. 2014; 26(5): 562 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Chronic inflammation and gallbladder cancer |
|
|
| Yumin Li,Junqiang Zhang,Haizhen Ma |
|
| Cancer Letters. 2013; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
